WILMINGTON, Mass. – July 30, 2009 – Ahura Scientific, Inc., a leader in rugged, ultra-compact handheld instruments for chemical identification, authentication and screening, today announced its preferred partner alliance with ProPharma Group, Inc. (PPG), which provides validation, compliance and technical services for the pharmaceutical, biotechnology and medical device industries.

Pharmaceutical and consumer health companies around the world are seeking new technologies to validate and qualify raw materials more efficiently and effectively. ProPharma Group’s Validation Services for TruScan, available now to companies that select Ahura Scientific’s TruScan™ handheld material identification product, will help expedite the implementation process and in turn shorten the adoption cycle of this technology. In addition, ProPharma Group’s existing customer base will benefit from the alliance through the introduction of TruScan, a new productivity tool that will help them cut costs in the areas of Quality Assurance (QA) and Quality Control (QC).

“Our TruScan customers in the pharmaceutical industry are pressed for time and short on resources. As a result, they require additional support for the validation and deployment of analytical instruments,” said Duane Sword, Vice President of Ahura Scientific. “With strengthening inspection rules from regulatory authorities, this partnership allows customers to engage with a consulting organization that can help them quickly implement groundbreaking solutions in a manufacturing environment and realize their benefits immediately.”

As a third party vendor, ProPharma Group offers unbiased expertise that is the direct result of its work helping most major pharmaceutical companies with their full range of validation requirements. ProPharma Group also possesses the ability to ensure a complete and rapid process validation through software-aided processes. Moving forward the company will assist Ahura Scientific’s customers throughout the deployment process by helping to develop and validate Standard Operating Procedures (SOPs) and identification methods under a GMP environment. The partnership will also allow ProPharma Group to create a validation plan for instrumentation and a process that encompasses both comparability protocol and regulatory filing.

“This partnership is emblematic of our commitment to quickly get the latest innovations into the hands of our customers so they can experience benefits immediately,” said Lance Tinseth, Vice President of ProPharma Group, Inc. “Through this partnership with Ahura Scientific, a company dedicated to manufacturing lifesaving products, we will be able to build on our track record of helping customers improve operations and ultimately stay compliant in a challenging and changing regulatory environment.”

All of the services offered through the Ahura Scientific and ProPharma Group alliance will be customized and developed to fit each customer’s specific process and regulatory needs, while providing each with the project management tools required to quickly realize the significant cost savings benefits delivered by TruScan. Validation Services for TruScan are now available for new and current customers. For more information on TruScan, please visit: http://www.ahurascientific.com/anti-counterfeiting/index.php.

About Ahura Scientific, Inc.

Ahura Scientific, Inc. is a leading provider of a new class of ultra-compact analytical instruments. These rugged handheld instruments are used for real-time identification of chemical substances, pharmaceutical authenticity testing, and threat screening. Customers include government agencies and companies in the safety and security, pharmaceutical, and consumer products markets. Manufactured in the USA in an ISO 9001-certified facility, the company's products offer exceptional portability and performance. For more information, visit www.ahurascientific.com.

About ProPharma Group, Inc.

ProPharma Group is an industry leader providing qualification, compliance and technical services to the pharmaceutical, biotechnology and medical device industries. We focus on enabling our customers to improve their operations, revitalize their facilities, and maintain quality leadership in a challenging and changing regulatory environment. We understand that our clients are driven by aggressive timelines and are comfortable working in such an environment while maintaining a strong integrity and commitment to compliance. For more information, visit www.propharmagroup.com.